We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TXNM:NYSETXNM Energy, Inc. Analysis

Data as of 2026-05-28 - not real-time

$59.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TXNM is trading just above its 20‑day SMA with a bullish MACD crossover and an RSI of 62, suggesting short‑term momentum, while the 30‑day volatility is low at under 3% and beta is near zero, indicating a very defensive price profile. The stock sits near its recent resistance of $59.53 and above the support at $58.67, and market sentiment is in the "Extreme Greed" zone, yet the forward PE of 18 contrasts sharply with a trailing PE of 42, far above the industry average, and the DCF fair‑value estimate is dramatically lower than the current price. Fundamentally, the company carries a massive debt‑to‑equity ratio above 160, a negative free cash flow, and a dividend payout ratio exceeding 100%, raising serious concerns about dividend sustainability.
Recent news highlights regulatory scrutiny over a $400 million stock sale to Blackstone and an $11.5 billion acquisition proposal, adding to the regulatory risk profile. The combination of overvalued multiples, high leverage, and questionable dividend coverage suggests limited upside despite the bullish technical setup, supporting a cautious stance for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (MACD, RSI)
  • Proximity to resistance and support levels
  • High market sentiment but overvalued price

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Elevated debt load and negative free cash flow
  • Unsustainable dividend payout
  • Regulatory scrutiny of major transactions

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistent overvaluation relative to fundamentals
  • Potential for earnings pressure from debt servicing
  • Uncertain dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin6.68%
P/E Ratio42.2
ROE5.41%
ROA2.06%
Debt/Equity163.55
P/B Ratio1.9
Op. Cash Flow$596.4M
Free Cash Flow$-634117504
Industry P/E21.9

Technical Analysis

TrendBullish
RSI62.7
Support$58.67
Resistance$59.53
MA 20$59.28
MA 50$58.97
MA 200$58.19
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5

Valuation

Fair Value$8.37
Target Price$60.79
Upside/Downside2.21%
GradeOvervalued
TypeGrowth
Dividend Yield2.84%

Risk Assessment

Beta0.06
Volatility2.88%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.